Swedish Orphan Biovitrum

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• 
  Change in number of shares and votes in Sobi (öffnet in neuem Tab)

  PR Newswire · 30.09.2026

• 
  Sobi to present clinical data on Gamifant® at Histiocyte Society 2026 in Rotterdam (öffnet in neuem Tab)

  24.09.2026

• Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates (öffnet in neuem Tab)

  22.09.2026

• 
  Sobi and Innate announce partnership is now effective following completion of closing conditions (öffnet in neuem Tab)

  17.09.2026

• 
  Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome (öffnet in neuem Tab)

  GlobeNewswire · 09.09.2026

• Sobi has completed an issue of class C shares (öffnet in neuem Tab)

  31.08.2026

• 
  Swedish Orphan Biovitrum (OM:SOBI) Following Its Lacutamab Deal And The Undervalued Narrative (öffnet in neuem Tab)

  Simply Wall St. · 15.08.2026

• 
  Swedish Orphan Biovitrum (OM:SOBI) Stock Looks Strong On Returns But Fully Priced On Earnings (öffnet in neuem Tab)

  Simply Wall St. · 14.08.2026

• Sobi licenses Innate’s CTCL drug for up to $580m as it heads to Phase III (öffnet in neuem Tab)

  10.08.2026

• Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma (öffnet in neuem Tab)

  10.08.2026

• German Covid vaccine pioneer BioNTech chooses new chief executive (öffnet in neuem Tab)

  03.08.2026

• 
  BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer (öffnet in neuem Tab)

  GlobeNewswire · 03.08.2026

• Guido Oelkers to step down as CEO of Sobi in the beginning of 2027 (öffnet in neuem Tab)

  03.08.2026

• Swedish Orphan Biovitrum AB (BIOVF) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... (öffnet in neuem Tab)

  GuruFocus.com · 18.07.2026

• Sobi Q2 2026 report: Significant growth with important pipeline progress (öffnet in neuem Tab)

  16.07.2026

• 
  Assessing Swedish Orphan Biovitrum’s Valuation After A Period Of Building Share Price Momentum (öffnet in neuem Tab)

  Simply Wall St. · 04.05.2026

• 
  Altuviiio (Swedish Orphan Biovitrum) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F (öffnet in neuem Tab)

  GlobeNewswire · 29.04.2026

• Swedish Orphan Biovitrum AB (BIOVF) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ... (öffnet in neuem Tab)

  GuruFocus.com · 29.04.2026

• 
  Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) (öffnet in neuem Tab)

  PR Newswire · 27.03.2026